SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001535610-14-000023
Filing Date
2014-01-16
Accepted
2014-01-16 10:51:00
Documents
1

Document Format Files

Seq Description Document Type Size
1 SABBY 13G-A SRPT 01.16.14 srpt0114.txt SC 13G/A 11769
  Complete submission text file 0001535610-14-000023.txt   13593
Mailing Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142
Business Address 215 FIRST STREET SUITE 7 CAMBRIDGE MA 02142 857-242-3700
Sarepta Therapeutics, Inc. (Subject) CIK: 0000873303 (see all company filings)

IRS No.: 930797222 | State of Incorp.: MA | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-54847 | Film No.: 14531210
SIC: 2834 Pharmaceutical Preparations

Mailing Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458
Business Address 10 MOUNTAINVIEW ROAD SUITE 205 UPPER SADDLE RIVER NJ 07458 646-307-4527
SABBY MANAGEMENT, LLC (Filed by) CIK: 0001535610 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A